Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases

被引：0
|
作者：
Crino, L. [1 ]
Horn, L. [2 ]
Felip, E. [3 ]
Frontera, O. Aren [4 ]
Burgio, M. [1 ]
Waterhouse, D. [5 ]
Blumenschein, G. [6 ]
Barlesi, F. [7 ]
Garassino, M. [8 ]
Holgado, E. [9 ]
Antonia, S. [10 ]
Spigel, D. [11 ]
Gainor, J. [12 ]
Gettinger, S. [13 ]
Geese, W. [14 ]
Li, A. [14 ]
Healey, D. [14 ]
Ready, N. [15 ]
机构：
[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori Irst, Meldola, Italy
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Hosp Univ Vall dHebron, Barcelona, Spain
[4] Ctr Int Estudios Clin, Santiago, Chile
[5] Oncol Hematol Care Ohc Us Oncol, Cincinnati, OH USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Aix Marseille Univ, AP HM, Marseille, France
[8] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[9] Hosp Madrid, Madrid, Spain
[10] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[11] Tennessee Oncol Pllc, Sarah Cannon Res Inst, Nashville, TN USA
[12] Massachusetts Gen Hosp, Boston, MA 02114 USA
[13] Yale Comprehens Canc Ctr, New Haven, CT USA
[14] Bristol Myers Squibb, Princeton, NJ USA
[15] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Nivolumab; non-small cell lung cancer;
D O I：
10.1016/j.jtho.2017.09.1703
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.07-012
引用
收藏
页码：S2302 / S2302
页数：1
相关论文
共 50 条
  • [21] Evaluation of Disease-Related Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer Treated with Nivolumab or Docetaxel
    Gralla, Richard J.
    Coon, Cheryl
    Taylor, Fiona
    Penrod, John R.
    Derosa, Michael
    Dastani, Homa
    Orsini, Lucinda
    Reck, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S233 - S234
  • [22] Three-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
    Felip Font, E.
    Gettinger, S. N.
    Burgio, M. A.
    Antonia, S. J.
    Holgado, E.
    Spigel, D. R.
    Arrieta, O.
    Domine Gomez, M.
    Aren Frontera, O.
    Brahmer, J.
    Chow, L. Q.
    Crino, L.
    Butts, C.
    Coudert, B.
    Horn, L.
    Steins, M.
    Geese, W. J.
    Li, A.
    Healey, D.
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Three-Year Follow-Up From checkMate 017/057: Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)
    Felip, Enriqueta
    Gettinger, Scott
    Burgio, Marco Angelo
    Antonia, Scott J.
    Holgado, Esther
    Spigel, David
    Arrieta, Oscar
    Domine, Manuel
    Aren Frontera, Osvaldo
    Brahmer, Julie
    Chow, Laura Q.
    Crino, Lucio
    Butts, Charles
    Coudert, Bruno
    Horn, Leora
    Steins, Martin
    Geese, William J.
    Li, Ang
    Healey, Diane
    Vokes, Everett E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 142 - 143
  • [24] Pseudoprogression in Previously Treated Patients with Non-Small Cell Lung Cancer Who Received Nivolumab Monotherapy
    Fujimoto, Daichi
    Yoshioka, Hiroshige
    Kataoka, Yuki
    Morimoto, Takeshi
    Hata, Tae
    Kim, Young Hak
    Tomii, Keisuke
    Ishida, Tadashi
    Hirabayashi, Masataka
    Hara, Satoshi
    Ishitoko, Manabu
    Fukuda, Yasushi
    Hwang, Moon Hee
    Sakai, Naoki
    Fukui, Motonari
    Nakaji, Hitoshi
    Morita, Mitsunori
    Mio, Tadashi
    Yasuda, Takehiro
    Sugita, Takakazu
    Hirai, Toyohiro
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 468 - 474
  • [25] Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases
    Kohei Fujita
    Naohiro Uchida
    Osamu Kanai
    Misato Okamura
    Koichi Nakatani
    Tadashi Mio
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 1105 - 1109
  • [26] Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases
    Fujita, Kohei
    Uchida, Naohiro
    Kanai, Osamu
    Okamura, Misato
    Nakatani, Koichi
    Mio, Tadashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1105 - 1109
  • [27] Nivolumab-induced Thyroid Dysfunctions in Patients with Previously Treated Non-small Cell Lung Cancer
    Xinyong Zhang
    Yuhua Wu
    Jialin Lv
    Xi Li
    Li Ma
    Jingying Nong
    Hui Zhang
    Na Qin
    Quan Zhang
    Guangli Shi
    Xinjie Yang
    Jinghui Wang
    Shucai Zhang
    Interdisciplinary Sciences: Computational Life Sciences, 2019, 11 : 287 - 291
  • [28] Nivolumab-induced Thyroid Dysfunctions in Patients with Previously Treated Non-small Cell Lung Cancer
    Zhang, Xinyong
    Wu, Yuhua
    Lv, Jialin
    Li, Xi
    Ma, Li
    Nong, Jingying
    Zhang, Hui
    Qin, Na
    Zhang, Quan
    Shi, Guangli
    Yang, Xinjie
    Wang, Jinghui
    Zhang, Shucai
    INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2019, 11 (02) : 287 - 291
  • [29] Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Alonso-Garcia, Miriam
    Sanchez-Gastaldo, Amparo
    Munoz-Fuentes, Miguel A.
    Molina-Pinelo, Sonia
    Boyero, Laura
    Benedetti, Johana Cristina
    Bernabe-Caro, Reyes
    PHARMACEUTICALS, 2022, 15 (05)
  • [30] Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab
    Cusato, Jessica
    Genova, Carlo
    Tomasello, Cristina
    Carrega, Paolo
    Ottonello, Selene
    Pietra, Gabriella
    Mingari, Maria Cristina
    Cossu, Irene
    Rijavec, Erika
    Leggieri, Anna
    Di Perri, Giovanni
    Dal Bello, Maria Giovanna
    Coco, Simona
    Boccardo, Simona
    Ferlazzo, Guido
    Grossi, Francesco
    D'Avolio, Antonio
    CANCERS, 2019, 11 (01):
12345